EUVIMEDEUVIMED entdecken
CrossrefInfokarte

Melanoma: Cutaneous, Version 2.2026, NCCN Clinical Practice Guidelines In Oncology

Susan M. Swetter, Douglas Johnson, Mark R. Albertini, Christopher A. Barker, Sarah Bateni, Joel Baumgartner, Shailender Bhatia, Christopher Bichakjian, Genevieve Boland, Sunandana Chandra, David Chen, Bartosz Chmielowski, Jacob Choi, Dominick DiMaio, Roxana Dronca, Martin D. Fleming, Anjela Galan, Samantha Guild, Siwen Hu-Lieskovan, Giorgos Karakousis, Kari Kendra, Maija Kiuru, Julie R. Lange, Ryan Lanning, Theodore Logan, Miguel Materin, Kelly Nelson, Daniel Olson, Anthony J. Olszanski, Patrick A. Ott, Igor Puzanov, Luke Rothermel, April K. Salama, Adrienne Shannon, Rohit Sharma, Arun Singh, Andrew Stacey, Katy Tsai, Evan Wuthrick, Yan Xing

Journal of the National Comprehensive Cancer Network · 2026-06 · 24 (6) · 272-277

DOI: 10.6004/jnccn.2026.0027 ↗
AbstractBibliografische Angaben

Abstract

The NCCN Guidelines for Melanoma: Cutaneous provide strategies for the diagnosis, treatment, and follow-up of patients with cutaneous melanoma, which is among the most common cancers in the United States. The outcome of cutaneous melanoma is significantly influenced by stage at initial presentation. Generally, localized disease and smaller primary tumors have been associated with more favorable prognosis. Thus, the select content featured in this issue focuses on risk factors associated with cutaneous melanoma development and which should be considered during an initial assessment. These include (1) phenotypic predispositions, (2) personal medical history or comorbidities, (3) genetic predispositions, and (4) environmental factors.

Wissen, das zu Ihrer Arbeit passt.

Vom kostenlosen Einstieg über die persönliche Recherche bis zur vollständigen Research Suite.

Tarife ansehen →

Sind alle Verlagsvolltexte enthalten?

Nein. Bibliografische Nachweise, Abstracts und Volltexte sind unterschiedliche Inhalte. Ob ein Volltext verfügbar ist, hängt von der Quelle, Open Access und Ihren vorhandenen Lizenzen ab. Ein EUVIMED-Tarif ersetzt keine zusätzlichen Verlagsrechte.

Tarife ansehen →